Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

NCT02767674 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

258

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma

Interventions

DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Cyclophosphamide
DRUG: Epirubicin Injectable Product
DRUG: Vindesine
DRUG: Prednisone

Sponsor

The First Affiliated Hospital with Nanjing Medical University